Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
Net Income (Common)
Jbm (Healthcare) Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jbm (Healthcare) Ltd
HKEX:2161
|
Net Income (Common)
HK$57.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
32%
|
CAGR 10-Years
53%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Net Income (Common)
¥2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
11%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
21%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Net Income (Common)
HK$3.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Net Income (Common)
$100.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
See Also
What is Jbm (Healthcare) Ltd's Net Income (Common)?
Net Income (Common)
57.1m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Net Income (Common) amounts to 57.1m HKD.
What is Jbm (Healthcare) Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
6%
Over the last year, the Net Income (Common) growth was 132%. The average annual Net Income (Common) growth rates for Jbm (Healthcare) Ltd have been 12% over the past three years , 6% over the past five years .